Pub. Date : 2021 Aug
PMID : 34089864
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Furthermore, pre-incubation of VSMCs with terpinen-4-ol or a SIRT1 agonist, decreased beta-GP-induced calcium salt deposition, increased SIRT1 protein level, and inhibited PERK-eIF2alpha-ATF4 pathway activation, thus, alleviating VC. | terpinenol-4 | sirtuin 1 | Mus musculus |
2 | Furthermore, pre-incubation of VSMCs with terpinen-4-ol or a SIRT1 agonist, decreased beta-GP-induced calcium salt deposition, increased SIRT1 protein level, and inhibited PERK-eIF2alpha-ATF4 pathway activation, thus, alleviating VC. | terpinenol-4 | sirtuin 1 | Mus musculus |
3 | Finally, inhibition of SIRT1 reduced the effect of terpinen-4-ol on the deacetylation of PERK in vitro and in vivo and weakened the inhibitory effect of terpinen-4-ol against ER stress-mediated VC. | terpinenol-4 | sirtuin 1 | Mus musculus |
4 | Finally, inhibition of SIRT1 reduced the effect of terpinen-4-ol on the deacetylation of PERK in vitro and in vivo and weakened the inhibitory effect of terpinen-4-ol against ER stress-mediated VC. | terpinenol-4 | sirtuin 1 | Mus musculus |
5 | Cumulatively, terpinen-4-ol was found to inhibit post-translational modification of PERK at the K889 acetylation site by upregulating SIRT1 expression, thereby ameliorating VC by regulating ER stress. | terpinenol-4 | sirtuin 1 | Mus musculus |